Skip to content
MARIO A. MONTEIRO
NEWS
Second human trial of our Campylobacter vaccine
WHO highlights our vaccines
LinkedIn
Home
A Brief Introduction
About Our Vaccine Research
Prof. Mario A. MONTEIRO (monteiro@uoguelph.ca)
Global Impact
Innovation Award
Canadian Immigrant Award
Teaching
CourseLink
High-school Activity
Clostridioides (Clostridium) difficile
C. difficile Polysaccharides
C. difficile Polysaccharide Vaccine
C. difficile polysaccharide Vaccine (pdf)
C. difficile vaccine for horses
C. difficile Vaccine Trials
Traveller’s Diarrhea
Campylobacter jejuni Vaccine
Campylobacter Conjugate Vaccine (pdf)
Campylobacter jejuni Vaccine Clinical Trial
Phase 1 Human Trial Results
Phase 1b Human Trial
Multivalent Diarrhea (C. jejuni/Shigella/ETEC) Vaccine
WHO highlights benefits of bivalent Shigella-ETEC conjugate vaccine
Autism-associated Bacteria
Studying the link between gut morbidity and autism-related symptoms
Enterocloster bolteae diagnostic/vaccine target
Clostridium bolteae polysaccharide immunogen
Clostridium bolteae carbohydrate scaffolds
Exploring Enterocloster bolteae carbohydrates
Research Impact
Cancer
Gastric cancer: Helicobacter pylori Lipopolysaccharides
Helicobacter Lipopolysaccharides (pdf)
Gastric cancer: Helicobacter pylori Lipopolysaccharide Vaccine
Colorectal cancer: Fusobacterium nucleatum Polysaccharides
New Conjugation Methodologies
TEMPO-mediated activation of polysaccharides
Conjugate vaccine syntheses via TEMPO-mediated activation
Otitis Media
Alloiococcus otitidis polysaccharide conjugate Vaccine
Immunoreactivity of Alloiococcus otitidis polysaccharide
Tuberculosis
TB vaccine research
Ruthenium Chloride Clusters
Creation of Ruthenium Chloride clusters
Composition of Ruthenium Blue
Veterinary Pathogens
Publications
Google Scholar
PubMed
Patents
Editor: Special Issue in Vaccines
Research Team
Alumna Dr. B. Pequegnat
Join Our Team
LUSOciência GOUVEIA 2024
Lista de Palestrantes
Gonçalo Bernardes
Tito Trindade
MARIO A. MONTEIRO
Toggle Menu
MARIO A. MONTEIRO
NEWS
Second human trial of our Campylobacter vaccine
WHO highlights our vaccines
LinkedIn
Home
A Brief Introduction
About Our Vaccine Research
Prof. Mario A. MONTEIRO (monteiro@uoguelph.ca)
Global Impact
Innovation Award
Canadian Immigrant Award
Teaching
CourseLink
High-school Activity
Clostridioides (Clostridium) difficile
C. difficile Polysaccharides
C. difficile Polysaccharide Vaccine
C. difficile polysaccharide Vaccine (pdf)
C. difficile vaccine for horses
C. difficile Vaccine Trials
Traveller’s Diarrhea
Campylobacter jejuni Vaccine
Campylobacter Conjugate Vaccine (pdf)
Campylobacter jejuni Vaccine Clinical Trial
Phase 1 Human Trial Results
Phase 1b Human Trial
Multivalent Diarrhea (C. jejuni/Shigella/ETEC) Vaccine
WHO highlights benefits of bivalent Shigella-ETEC conjugate vaccine
Autism-associated Bacteria
Studying the link between gut morbidity and autism-related symptoms
Enterocloster bolteae diagnostic/vaccine target
Clostridium bolteae polysaccharide immunogen
Clostridium bolteae carbohydrate scaffolds
Exploring Enterocloster bolteae carbohydrates
Research Impact
Cancer
Gastric cancer: Helicobacter pylori Lipopolysaccharides
Helicobacter Lipopolysaccharides (pdf)
Gastric cancer: Helicobacter pylori Lipopolysaccharide Vaccine
Colorectal cancer: Fusobacterium nucleatum Polysaccharides
New Conjugation Methodologies
TEMPO-mediated activation of polysaccharides
Conjugate vaccine syntheses via TEMPO-mediated activation
Otitis Media
Alloiococcus otitidis polysaccharide conjugate Vaccine
Immunoreactivity of Alloiococcus otitidis polysaccharide
Tuberculosis
TB vaccine research
Ruthenium Chloride Clusters
Creation of Ruthenium Chloride clusters
Composition of Ruthenium Blue
Veterinary Pathogens
Publications
Google Scholar
PubMed
Patents
Editor: Special Issue in Vaccines
Research Team
Alumna Dr. B. Pequegnat
Join Our Team
LUSOciência GOUVEIA 2024
Lista de Palestrantes
Gonçalo Bernardes
Tito Trindade
Carbohydrate-based Vaccines and Diagnostics
